News - Global

Filter

Current filters:

Global

Popular Filters

10 to 34 of 305 results

Interview: Arnaud Grunwald of Model N on taking a holistic approach to revenue management

Interview: Arnaud Grunwald of Model N on taking a holistic approach to revenue management

20-03-2014

As health care budgets are squeezed worldwide and access issues continue to make the headlines, the price…

GlobalInterviewsPharmaceuticalPricing

Global epilepsy market to reach $4.5 billion by 2019

Global epilepsy market to reach $4.5 billion by 2019

13-03-2014

The epilepsy therapeutics market value in the eight major countries - the USA, Canada, France, Germany,…

EisaiFycompaGlaxoSmithKlineGlobalMarkets & MarketingNeurologicalPharmaceuticalTrobaltUCBVimpat

Sustainability of sky-high M&A valuations will be the biggest question for 2014, says new report

12-03-2014

The cautious optimism of 2012 turned into a fully fledged biotech boom in 2013, marked by surging company…

BiotechnologyGlobalMergers & AcquisitionsPharmaceutical

Report: Reform and legislation is affecting global market access

Report: Reform and legislation is affecting global market access

07-03-2014

Landmark healthcare legislation in developed markets, combined with evolving regulatory trends in emerging…

GlobalMarkets & MarketingPharmaceuticalResearch

Report: R&D market is diversifying innovation, with increased partnerships, mergers and revenue sharing models

06-03-2014

The R&D sector is set to grow at more than 8% driven by new evaluation techniques, according to CPhI…

FinancialGlobalPharmaceuticalResearch

Sanofi Pasteur wins order for IPV from UNICEF, cutting price to $1 per dose

28-02-2014

Sanofi Pasteur, the vaccines division of French drug major Sanofi, says that UNICEF, the organization…

GlobalMarkets & MarketingPharmaceuticalPricingSanofiSanofi PasteurVaccines

Viiv Healthcare comes out top in global survey of pharma industry reputations

14-02-2014

An independent global study has recorded the latest impressions of the corporate reputation of the world’s…

AbbVieGlobalPharmaceuticalResearchViiV Healthcare

Survey: Pharma CEOs on the importance of technology, demographics and innovation

Survey: Pharma CEOs on the importance of technology, demographics and innovation

07-02-2014

A global survey of chief executives has revealed the priorities and concerns of pharmaceutical and life…

BiotechnologyBoardroomGlobalMarkets & MarketingPharmaceutical

Gilead to offer hep C drug sofosbuvir at greatly-reduced price in developing countries

Gilead to offer hep C drug sofosbuvir at greatly-reduced price in developing countries

07-02-2014

US biotech Gilead Sciences has indicated it would charge $2,000 per 24 week treatment course for the…

Anti-viralsBiotechnologyGilead SciencesGlobalIndiaPricingsofosbuvirSovaldi

Absence of blockbuster drug launches in 2014 puts R&D productivity at risk

05-02-2014

The past two years have brought a surge of R&D productivity, driving investor confidence and increasing…

GlobalMarkets & MarketingPharmaceuticalResearch

Report: Innovative medicines could deliver increased benefits in middle-income countries

Report: Innovative medicines could deliver increased benefits in middle-income countries

29-01-2014

There is clear evidence that innovative medicines have delivered significant value by reducing healthcare…

GlobalHealthcarePharmaceutical

UCB launches online search for rare phenotypes

UCB launches online search for rare phenotypes

28-01-2014

Belgian drugmaker UCB (Euronext Brussels: UCB) has launched an online search to find rare phenotypes…

GeneticsGlobalPharmaceuticalRare diseasesResearchUCB

Promising late-stage GI drugs could stabilize global market decline; report

16-01-2014

The gastrointestinal (GI) therapeutics market for irritable bowel syndrome (IBS), ulcerative colitis…

BiosimilarsGastro-intestinalsGlobalMarkets & MarketingPharmaceuticalRemicadeTakeda Pharmaceuticalsvedolizumab

Pharma industry prospects in “non-traditional” markets

15-01-2014

As tight fiscal budgets continue to restrict medicine sales in developed markets (primarily Europe, but…

GlobalMarkets & MarketingPharmaceutical

Jazz Pharma in $397 million deal with Aerial for narcolepsy drug ADX-NO5

14-01-2014

Ireland-headquartered drugmaker Jazz Pharmaceuticals has inked an agreement with the USA’s Aerial BioPharma…

ADX-NO5Aerial BioPharmaGlobalJazz PharmaceuticalsLicensingNeurologicalPharmaceutical

Big pharma's need to tap M&A for growth will persist in 2014, while dealmaking landscape becomes more competitive, says EY

13-01-2014

Big pharma stayed on the sidelines in the 2013 mergers and acquisitions market despite a continuing need…

GlobalMergers & AcquisitionsPharmaceutical

Pharma M&A deals in 2013 down, but values marginally higher

Pharma M&A deals in 2013 down, but values marginally higher

13-01-2014

Merger and acquisition activity in the pharmaceutical, biotechnology and generic drugs sectors continued…

BiotechnologyGlobalMergers & AcquisitionsPharmaceutical

Nanomedicines market to reach $177.6 billion globally in 2019

08-01-2014

The global market for nanomedicine was valued at $78.54 billion in 2012 and is expected to reach a value…

BiotechnologyCardio-vascularGlobalMarkets & MarketingOncology

10 to 34 of 305 results

Back to top